Live Breaking News & Updates on Post Hoc Subset Analysis From

Stay updated with breaking news from Post hoc subset analysis from. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Latest XCOPRI® (cenobamate tablets) CV Post-hoc Analysis Presented at the 75th American Academy of Neurology Annual Meeting

SK Life Science will present analysis of 2,131 patients taking cenobamate during Phase 2 and 3 trials showing sudden unexpected death in epilepsy (SUDEP) rate. ....

United States , United Kingdom , Williame Rosenfeld , Angelini Pharma , Louis Ferrari , Dina Albanese , Source Sk Life Science Inc , Sk Inc , Sk Biopharmaceuticals Co Ltd , Sk Group , American Academy Of Neurology , Sk Life Science Inc , Epilepsy Foundation , Epilepsy Care Center , European Union , Pharmacological Treatments , Refractory Epilepsy , Its Prevention , American Academy , Annual Meeting , Vice President , Medical Affairs , Comprehensive Epilepsy Care Center , Response With Cenobamate , Post Hoc Subset Analysis From , Open Label Safety ,